EUVIMEDEUVIMED entdecken
Crossref

Elevated myocardial extracellular volume fraction is associated with the development of conduction pathway defects following transcatheter aortic valve replacement

Rafey Feroze, Puneet Kang iD, Luis Augusto Palma Dallan, Navya Akula, Jason Galo iD, Sung-Han Yoon iD, Anene Ukaigwe, Steven J Filby iD, Cristian Baeza, Marc Pelletier, Gregory Rushing, Sanjay Rajagopalan und 3 weitere

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.31136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Rafey Feroze und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Fibrosis, Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Myocardium. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: NHLBI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transcatheter aortic valve replacement (TAVR) has become an established method of aortic stenosis treatment but suffers from the risk of heart block and pacemaker requirement. Risk stratification for patients who may develop heart block remains imperfect. Simultaneously, myocardial fibrosis as measured by cardiac magnetic resonance imaging (CMR) has been demonstrated as a prognostic indicator of ventricular recovery and mortality following TAVR. However, the association of CMR‐based measures of myocardial fibrosis with post‐TAVR conduction disturbances has not yet been explored.

Aims

We evaluated whether myocardial fibrosis, as measured by late gadolinium enhancement and extracellular volume (ECV) from CMR would be associated with new conduction abnormalities following TAVR.

Methods

One hundred seventy patients who underwent CMR within 2 months before TAVR were retrospectively reviewed. Septal late gadolinium enhancement (LGE) and ECV measurements were made as surrogates for replacement and interstitial fibrosis respectively. New conduction abnormalities were defined by the presence of transient or permanent atrioventricular block, new bundle branch blocks, and need for permanent pacemaker. Association of myocardial fibrosis and new conduction derangements were tested using receiver operator curve (ROC) and regression analysis in patients with and without pre‐existing conduction issues.

Results

Forty‐six (27.1%) patients developed post‐TAVR conduction deficits. ECV was significantly higher among patients who experienced new conduction defects (26.2 ± 3.45% vs. 24.7% ± 4.15%, p value: 0.020). A greater fraction of patients that had new conduction defects had an elevated ECV of ≥26% (54.3% vs. 36.3%, p value: 0.026). ECV ≥ 26% was independently associated with the development of new conduction defects (odds ratio [OR]: 2.364, p value: 0.030). ROC analysis revealed a significant association of ECV with new conduction defects with an area under the receiver operating characteristic curve (AUC) of 0.632 (95% confidence interval: 0.555–0.705, p value: 0.005). The combination of prior right bundle branch block (RBBB) and ECV revealed a greater AUC of 0.779 (0.709–0.839, p value:

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisAortic Valve StenosisTranscatheter Aortic Valve ReplacementMyocardiumPredictive Value of TestsHumansMaleFemaleRetrospective StudiesAged, 80 and overAgedTreatment OutcomeRisk FactorsAction PotentialsMagnetic Resonance Imaging, CineHeart Conduction SystemAortic ValveAtrioventricular BlockBundle-Branch BlockCardiac Pacing, ArtificialTime FactorsPacemaker, ArtificialArea Under CurveROC CurveRisk Assessment

Stichwörter der Autor:innen

CMRTAVRconduction defectsextracellular volume fraction

Autor:innen und Institutionen

  • Division of Cardiology, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Division of Cardiovascular Surgery, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

ORCID-Profile: Puneet Kang, Jason Galo, Sung-Han Yoon, Steven J Filby, Guilherme F Attizzani

Förderung

  • NHLBI NIH HHS
  • NIH HHS

Zitieren

APA

Feroze, R., Kang, P., Dallan, L. A. P., Akula, N., Galo, J., Yoon, S. H., Ukaigwe, A., Filby, S. J., Baeza, C., Pelletier, M., Rushing, G., Rajagopalan, S., Al-Kindi, S., Rashid, I., & Attizzani, G. F. (2024). Elevated myocardial extracellular volume fraction is associated with the development of conduction pathway defects following transcatheter aortic valve replacement. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31136

Vancouver

Feroze R, Kang P, Dallan LAP, Akula N, Galo J, Yoon SH, et al. Elevated myocardial extracellular volume fraction is associated with the development of conduction pathway defects following transcatheter aortic valve replacement. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31136

BibTeX
@article{Feroze2024,
  author = {Feroze, Rafey and Kang, Puneet and Dallan, Luis Augusto Palma and Akula, Navya and Galo, Jason and Yoon, Sung-Han and Ukaigwe, Anene and Filby, Steven J and Baeza, Cristian and Pelletier, Marc and Rushing, Gregory and Rajagopalan, Sanjay and Al-Kindi, Sadeer and Rashid, Imran and Attizzani, Guilherme F},
  title = {Elevated myocardial extracellular volume fraction is associated with the development of conduction pathway defects following transcatheter aortic valve replacement},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.31136}
}
Kostenlos starten →